ATUM Competitors and Similar CompaniesClear all
ATUM's competitors and similar companies include OCTIMET Oncology, NeRRe Therapeutics and Vita 34.
 OCTIMET Oncology OCTIMET develops highly selective MET kinase inhibitors with clean safety profiles from Janssen Pharmaceutica. |  NeRRe Therapeutics NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. |  Vita 34 Vita 34 is the largest and the most experienced umbilical cord blood bank for medical precaution by means of stem cells in the German-speaking countries. | ||
Founding Date | Founding Date 2003 | Founding Date 2016 | Founding Date 2012 | Founding Date 1997 |
Type | Type Private | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Newark, US HQ | Locations Beerse, BE HQ Gent, BE | Locations Stevenage, GB HQ Hertfordshire, GB | Locations Leipzig, DE HQ Leipzig, DE |
Employees | Employees 1292% increase | Employees 1 | Employees 9 | Employees 771 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 13.4m (over 9 years ago) | Latest funding round $ 30.8m (over 9 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 13.4m | Total funding raised $ 49.2m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
OCTIMET Oncology
HQ
Beerse, BE
Employees
1
OCTIMET develops highly selective MET kinase inhibitors with clean safety profiles from Janssen Pharmaceutica.
View companyNeRRe Therapeutics
HQ
Stevenage, GB
Employees
9
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
View companyVita 34
HQ
Leipzig, DE
Employees
771
Vita 34 is the largest and the most experienced umbilical cord blood bank for medical precaution by means of stem cells in the German-speaking countries.
View company